Kala Bio annual debt-to-assets ratio
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Kala Bio's debt-to-assets ratio was 0.00 for fiscal 2025.
View full Kala Bio company overview| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | −0.58 | — |
| 2024 | 2024-12-31 | 0.58 | −0.07 | −10.46% |
| 2023 | 2023-12-31 | 0.65 | 0.15 | +31.27% |
| 2022 | 2022-12-31 | 0.49 | −0.08 | −14.59% |
| 2021 | 2021-12-31 | 0.58 | 0.12 | +27.16% |
| 2020 | 2020-12-31 | 0.46 | −0.20 | −30.55% |
| 2019 | 2019-12-31 | 0.66 | 0.21 | +45.69% |
| 2018 | 2018-12-31 | 0.45 | 0.29 | +175.31% |
| 2017 | 2017-12-31 | 0.16 | −0.04 | −21.55% |
| 2016 | 2016-12-31 | 0.21 | — | — |
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.00 | −0.58 | — |
| Q3 2025 | 2025-09-30 | 1.14 | 0.45 | +66.19% |
| Q2 2025 | 2025-06-30 | 0.83 | 0.23 | +38.97% |
| Q1 2025 | 2025-03-31 | 0.67 | −0.02 | −2.76% |
| Q4 2024 | 2024-12-31 | 0.58 | −0.07 | −10.46% |
| Q3 2024 | 2024-09-30 | 0.68 | 0.09 | +16.02% |
| Q2 2024 | 2024-06-30 | 0.60 | 0.09 | +18.34% |
| Q1 2024 | 2024-03-31 | 0.69 | 0.23 | +49.67% |
| Q4 2023 | 2023-12-31 | 0.65 | 0.15 | +31.27% |
| Q3 2023 | 2023-09-30 | 0.59 | 0.09 | +18.64% |
| Q2 2023 | 2023-06-30 | 0.50 | −0.43 | −46.28% |
| Q1 2023 | 2023-03-31 | 0.46 | −0.26 | −36.33% |
| Q4 2022 | 2022-12-31 | 0.49 | −0.08 | −14.59% |
| Q3 2022 | 2022-09-30 | 0.50 | −0.05 | −9.90% |
| Q2 2022 | 2022-06-30 | 0.94 | 0.44 | +89.06% |
| Q1 2022 | 2022-03-31 | 0.72 | 0.28 | +62.97% |
| Q4 2021 | 2021-12-31 | 0.58 | 0.12 | +27.16% |
| Q3 2021 | 2021-09-30 | 0.55 | 0.10 | +23.09% |
| Q2 2021 | 2021-06-30 | 0.50 | 0.09 | +20.76% |
| Q1 2021 | 2021-03-31 | 0.44 | 0.05 | +13.50% |
| Q4 2020 | 2020-12-31 | 0.46 | −0.20 | −30.55% |
| Q3 2020 | 2020-09-30 | 0.45 | −0.18 | −28.64% |
| Q2 2020 | 2020-06-30 | 0.41 | −0.16 | −27.61% |
| Q1 2020 | 2020-03-31 | 0.39 | −0.12 | −24.20% |
| Q4 2019 | 2019-12-31 | 0.66 | 0.21 | +45.69% |
| Q3 2019 | 2019-09-30 | 0.63 | 0.39 | +165.78% |
| Q2 2019 | 2019-06-30 | 0.57 | 0.36 | +172.19% |
| Q1 2019 | 2019-03-31 | 0.52 | 0.33 | +170.27% |
| Q4 2018 | 2018-12-31 | 0.45 | 0.29 | +175.31% |
| Q3 2018 | 2018-09-30 | 0.24 | 0.08 | +48.24% |
| Q2 2018 | 2018-06-30 | 0.21 | −0.13 | −38.49% |
| Q1 2018 | 2018-03-31 | 0.19 | — | — |
| Q4 2017 | 2017-12-31 | 0.16 | −0.04 | −21.55% |
| Q3 2017 | 2017-09-30 | 0.16 | — | — |
| Q2 2017 | 2017-06-30 | 0.34 | — | — |
| Q4 2016 | 2016-12-31 | 0.21 | — | — |
Over the last five fiscal years, Kala Bio's debt-to-assets ratio decreased from 0.46 to 0.00, a change of −0.46. The latest reported quarter, Q4 2025, shows 0.00.
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kala Bio source filings ↗